Patents Assigned to Nanocopoeia, Inc.
  • Patent number: 10252289
    Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial dual capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: April 9, 2019
    Assignee: NANOCOPOEIA, INC.
    Inventors: Robert A. Hoerr, John V. Carlson
  • Patent number: 9642694
    Abstract: Devices to deliver one or more active ingredients for medical treatment may include a body of material presenting a surface including a polymer adapted to be rendered conductive such that one or more layers of electrospray particles are formable thereon or a body of conductive material presenting a surface upon which one or more layers of electrospray particles are formable thereon. A coating formed of electrospray particles may be deposited to adhere on the surface of the body of material (e.g., the coating may include one or more layers of coating material, at least one layer of the one or more layers of coating material may include an open matrix coating, the open matrix coating may include one or more active ingredients, the open matrix coating may include one or more polymers and one or more active ingredients, etc.).
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: May 9, 2017
    Assignees: REGENTS OF THE UNIVERSITY OF MINNESOTA, NANOCOPOEIA, INC.
    Inventors: Robert A. Hoerr, Da-Ren Chen, John V. Carlson, David Y. H. Pui
  • Patent number: 9108217
    Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial dual capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: August 18, 2015
    Assignee: Nanocopoeia, Inc.
    Inventors: Robert A. Hoerr, John V. Carlson
  • Publication number: 20150158051
    Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial dual capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.
    Type: Application
    Filed: January 31, 2008
    Publication date: June 11, 2015
    Applicant: Nanocopoeia, Inc.
    Inventors: Robert A. Hoerr, John V. Carlson
  • Patent number: 9040816
    Abstract: Methods of forming a photovoltaic structures including nanoparticles are disclosed. The method includes electrospray deposition of nanoparticles. The nanoparticles can include TiO2 nanoparticles and quantum dots. In an example, the nanoparticles are formed on a flexible substrate. In various examples, the flexible substrate is light transparent. Photovoltaic structures and apparatus for forming photovoltaic structures are disclosed.
    Type: Grant
    Filed: December 10, 2007
    Date of Patent: May 26, 2015
    Assignee: Nanocopoeia, Inc.
    Inventor: Anand Gupta
  • Patent number: 8992603
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: March 31, 2015
    Assignees: Nanocopoeia, Inc., Louisiana State University Health Sciences Center Office of Research
    Inventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, John Devlin Foley
  • Patent number: 8992471
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Grant
    Filed: November 5, 2008
    Date of Patent: March 31, 2015
    Assignees: Nanocopoeia, Inc., Louisiana State University Health Sciences Center Office of Research
    Inventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, III, John Devlin Foley
  • Publication number: 20130323403
    Abstract: Electrospray methods and systems for coating of objects (e.g., medical devices such as a stent structure) with selected types of coatings (e.g., open matrix coating and closed film coating).
    Type: Application
    Filed: May 24, 2013
    Publication date: December 5, 2013
    Applicants: REGENTS OF THE UNIVERSITY OF MINNESOTA, NANOCOPOEIA, INC.
    Inventors: ROBERT A. HOERR, DA-REN CHEN, JOHN V. CARLSON, DAVID Y.H. PUI
  • Publication number: 20130030518
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Application
    Filed: October 2, 2012
    Publication date: January 31, 2013
    Applicants: LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER OFFICE OF RESEARCH, NANOCOPOEIA, INC.
    Inventors: Tammy R. DUGAS, Alok KHANDELWAL, James John KLEINEDLER, III, John Devlin FOLEY
  • Publication number: 20110229627
    Abstract: Electrospray methods and systems for coating of objects (e.g., medical devices such as a stent structure) with selected types of coatings (e.g.
    Type: Application
    Filed: May 27, 2011
    Publication date: September 22, 2011
    Applicants: NANOCOPOEIA, INC., Regents of the University of Minnesota
    Inventors: ROBERT A. HOERR, JOHN V. CARLSON, DA-REN CHEN, DAVID Y.H. PUI
  • Publication number: 20100331965
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Application
    Filed: November 5, 2008
    Publication date: December 30, 2010
    Applicant: NANOCOPOEIA, INC.
    Inventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, III, John Devlin Foley
  • Publication number: 20070278103
    Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a hydrogel surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.
    Type: Application
    Filed: January 31, 2007
    Publication date: December 6, 2007
    Applicant: Nanocopoeia, Inc.
    Inventors: Robert Hoerr, John Carlson